TipRanks
Go Ultimate55% OFF

Johnson & Johnson (1JNJ) Stock Forecast & Price Target

See the Price Targets and Ratings of:All AnalystsTop AnalystsPremium

1JNJ Analyst Ratings

Moderate Buy
17Ratings
11Buy6Hold0Sell
Based on 17 analysts giving stock ratings to Johnson & Johnson in the past 3 months

1JNJ Stock 12 Month Forecast

EUR 258.78▲(4.83% Upside)
Based on 17 Wall Street analysts offering 12 month price targets for Johnson & Johnson in the last 3 months. The average price target is EUR 258.78 with a high forecast of EUR 287.65 and a low forecast of EUR 233.72. The average price target represents a 4.83% change from the last price of EUR 246.85.
Highest Price TargetEUR 287.65Average Price TargetEUR 258.78Lowest Price TargetEUR 233.72

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for IT:1JNJ
Price TargetFollowArticle
RBC CapitalEUR 251.70buy1.96%UpsideReiterated10/27/26
Leerink PartnersEUR 244.51buy-0.95%DownsideReiterated10/27/26
ScotiabankEUR 274.17buy11.07%UpsideReiterated10/26/26
Goldman SachsEUR 251.70buy1.96%UpsideReiterated10/26/26
UBSEUR 287.65buy16.53%UpsideReiterated10/25/26
Erste Group―hold―Downgraded10/21/26
TD CowenEUR 269.68buy9.25%UpsideAssigned10/19/26
Wells FargoEUR 247.20→EUR 257.99buy4.51%UpsideReiterated10/15/26
Morgan StanleyEUR 264.28→EUR 262.48buy6.33%UpsideReiterated10/15/26
Bank of America SecuritiesEUR 247.20hold0.14%UpsideReiterated10/14/26
BernsteinEUR 234.62→EUR 242.71hold-1.68%DownsideReiterated10/14/26
Stifel NicolausEUR 233.72hold-5.32%DownsideReiterated10/12/26
GuggenheimEUR 257.99buy4.51%UpsideReiterated10/06/26
CitiEUR 267.88→EUR 272.37buy10.34%UpsideReiterated10/05/26
J.P. MorganEUR 242.71→EUR 256.19hold3.78%UpsideReiterated09/29/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
AORTArtivion
MDWDMediwound
IMUXImmunic
RZLTRezolute
DFTXDefinium Therapeutics

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Johnson & Johnson

3 Months
Asad Haider
Asad HaiderGoldman Sachs
Success Rate12/15 ratings generated profit
80%
Average Return
+9.40%

Copying Asad Haider's trades and holding each position for 3 Months would result in 80.00% of your transactions generating a profit, with an average return of +9.40% per trade.

1 Year
Asad Haider
Asad HaiderGoldman Sachs
Success Rate15/15 ratings generated profit
100%
Average Return
+30.95%

Copying Asad Haider's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +30.95% per trade.

2 Years
Asad Haider
Asad HaiderGoldman Sachs
Success Rate15/15 ratings generated profit
100%
Average Return
+35.41%

Copying Asad Haider's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +35.41% per trade.

1JNJ Analyst Recommendation Trends

020406080Oct 25Nov 25Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26
Monthly rating counts for 1JNJ
RatingMay 26Jun 26Jul 26Aug 26Sep 26
Strong Buy00000
Buy2637414437
Hold987109
Sell00000
Strong Sell00000
total3545485446

In the current month, 1JNJ has received 37 Buy Ratings, 9 Hold Ratings, and 0 Sell Ratings. 1JNJ average Analyst price target in the past 3 months is 258.78.

1JNJ Financial Forecast

EUR 1EUR 1.5EUR 2EUR 2.5EUR 3Q1 2026Q3 2026Q4 2026
HighEUR 2.65
ConsensusEUR 2.60
LowEUR 2.45

1JNJ Earnings Forecast

Next quarter’s earnings estimate for 1JNJ is EUR 2.60 with a range of EUR 2.45 to EUR 2.65. The previous quarter’s EPS was EUR 2.32. 1JNJ beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year 1JNJ has Performed in-line its overall industry.

EUR 21.5BEUR 22.1BEUR 22.7BEUR 23.3BEUR 23.9BQ1 2026Q3 2026Q4 2026
HighEUR 23.9B
ConsensusEUR 23.6B
LowEUR 23.5B

1JNJ Sales Forecast

Next quarter’s sales forecast for 1JNJ is EUR 23.64B with a range of EUR 23.48B to EUR 23.89B. The previous quarter’s sales results were EUR 22.74B. 1JNJ beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year 1JNJ has Performed in-line its overall industry.

1JNJ Stock Forecast FAQ

What is IT:1JNJ’s average 12-month price target, according to analysts?
Based on analyst ratings, Johnson & Johnson’s 12-month average price target is €258.78.
What is IT:1JNJ’s upside potential, based on the analysts’ average price target?
Johnson & Johnson has 4.83% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Johnson & Johnson a Buy, Sell or Hold?
Johnson & Johnson has a consensus rating of Moderate Buy, which is based on 11 buy ratings, 6 hold ratings and 0 sell ratings.
What is Johnson & Johnson’s share price target?
The average share price target for Johnson & Johnson is €258.78. This is based on 17 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is €287.65, and the lowest forecast is €233.72. The average share price target represents a 4.83% increase from the current price of €246.85.
What do analysts say about Johnson & Johnson?
Johnson & Johnson’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 17 Wall Street analysts.
How can I buy shares of Johnson & Johnson?
To buy shares of IT:1JNJ, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.